Stockreport

Vir Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Vir Biotechnology, Inc.  (VIR) 
PDF SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology Inc. (NASDAQ: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer is scheduled [Read more]